跳至主要内容
临床试验/NCT03812120
NCT03812120Unknown不适用

L-PRF in Cranial Surgery: a Prospective, Randomized Trial

Universitaire Ziekenhuizen KU Leuven2 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2018年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
350
试验地点
2
主要终点
Success rate

研究概览

简要总结

The investigators want to demonstrate in a prospective, randomized trial including 350 patients undergoing cranial surgery that the use of L-PRF is non-inferior to classical fibrin sealants.

详细描述

The investigators want to demonstrate in a prospective, randomized trial including 350 patients undergoing cranial surgery that the use of L-PRF is non-inferior to classical fibrin sealants.

Approximately 350 patients undergoing cranial surgery will be enrolled in this randomized, controlled, single-blinded monocenter study to evaluate the safety and effectiveness of autologous blood-derived products (L-PRF and fibrinogen) compared to the fibrin sealants as an adjunct for dural repair (= primary objective).

The investigators will also evaluate if the use of L-PRF obviates the need for the use of other autologous grafts (e.g. muscle/fat), commercial collagen-based products (e.g. Tachosil) or articifial dura (=secondary objective).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

盲法说明

Participants stay masked during the trial, care provider and investigators are unblinded at the surgical procedure and from thereon.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing cranial neurosurgery whereby the dura is intentionally opened (supratentorial and infratentorial approach)
  • Age ≥ 18 years
  • Written informed consent
  • Willing to comply with the study schedule

排除标准

  • Participation in another clinical trial with study drugs or devices
  • Pregnancy

研究组 & 干预措施

Classical Treatment

Placebo Comparator

In this arm, dural closure will be performed with the classical fibrine sealants.

干预措施: Dural closure with classical fibrin sealants (Procedure)

L-PRF

Active Comparator

In this arm, dural closure will be performed with the autologous L-PRF

干预措施: Dural closure with L-PRF (Procedure)

结局指标

主要结局

Success rate

时间窗: 4 years

The success rate is considered a thigh closure of the dura in both groups, which means no CSF leakage. This success rate was estimated at 95% in both techniques.

次要结局

  • Cost effectiveness evaluation(4 years)
  • Complications(4 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tom Theys

Professor, Dr

Universitaire Ziekenhuizen KU Leuven

研究点 (2)

Loading locations...

相似试验